InnovaDerma
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of InnovaDerma generated cash of $2,016,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$1,606,000,000 last year. Net change in cash is therefore $25,000,000.

Cash Flow

InnovaDerma PLC (LSE:IDP.L): Cash Flow
2016 -235.99K -34.86K 254.25K
2018 102.31K -2.06M 3.51M
2020 2.08B -733M -1.32B
2021 1.59B -1.17B -474M
2021 2.01B -384M -1.60B

IDP.L Cash Flow Statement (2015 – 2021)

2021 2020 2019 2017 2015
Cash at beginning of period
88M138M114M207.30K118.95K
Operating activities
Net income
1.47B1.22B1.50B414.19K194.34K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
429M524M434M95.86K1.20K
Stock-based compensation expense
45M25M32M00
Deferred income tax benefit 45M25M32M00
Changes in operating assets and liabilities:
Accounts receivable, net
-103M149M-116M00
Inventories
-73M-80M-14M-614.54K-428.46K
Accounts payable
0229K-1.64M00
Cash generated by operating activities
2.01B1.59B2.08B102.31K-235.99K
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-28M-43M-47M-2.06M-34.86K
Acquisitions Net
0-59K000
Cash generated by investing activities
-384M-1.17B-733M-2.06M-34.86K
Financing activities
Common Stock Issued
525M3.52M1.35B4.41M35.58K
Payments for dividends
-920M-880M-842M00
Repurchases of common stock
-1M-187M-637M00
Repayments of term debt
-524M-1.33B-719M-392.21K0
Cash used in financing activities
-1.60B-474M-1.32B3.51M254.25K
Net Change In Cash
25M-50M24M1.69M-2.76K
Cash at end of period
113M88M138M1.90M116.19K
Data sourceData sourceData sourceData sourceData source